Spray drying formulation of hollow spherical aggregates of silica nanoparticles by experimental design

The present work employs an experimental design methodology to optimize the spray-drying production of micron-size hollow aggregates of biocompatible silica nanoparticles that are aimed to serve as drug delivery vehicles in inhaled photodynamic therapy. To effectively deliver the nanoparticles to the lung, the aerodynamic size (dA) of the nano-aggregates, which is a function of the geometric size (dG) and the degree of hollowness, must fall within a narrow range between 2 and 4 μm. The results indicate that (1) the feed concentration, (2) the feed pH, and (3) the ratio of the gas atomizing flow rate to the feed rate are the three most significant parameters governing the nano-aggregate morphology. Spray drying at a low pH (<7) and at a low feed concentration (<1%, w/w) generally results in nano-aggregates having small geometric and aerodynamic sizes (dA = dG ≈ 3 μm) with a relatively monodisperse size distribution. Spray drying at a higher feed concentration produces nano-aggregates having a larger dG but with a multimodal particle size distribution. A trade-off therefore exists between having large dG to improve the aerosolization efficiency and obtaining a uniform particle size distribution to improve the dose uniformity.

[1]  C. Roux,et al.  Ti-Cp functionalization by deposition of organic/inorganic silica nanoparticles. , 2007, Biomolecular engineering.

[2]  C. Barbé,et al.  Silica Particles: A Novel Drug‐Delivery System , 2004 .

[3]  J. Wiegmann,et al.  The chemistry of silica. Solubility, polymerization, colloid and surface properties, and biochemistry. Von RALPH K. ILER. New York/Chichester/Brisbane/Toronto: John Wiley & Sons 1979. XXIV, 866 S., Lwd., £ 39.50 , 1980 .

[4]  H. Linden,et al.  The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. , 2002, International journal of pharmaceutics.

[5]  D A Weitz,et al.  Trojan particles: Large porous carriers of nanoparticles for drug delivery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Saleh,et al.  An experimental study of fluidized-bed coating : influence of operating conditions on growth rate and mechanism , 1999 .

[7]  Evert Schepers,et al.  In vivo tissue response to resorbable silica xerogels as controlled-release materials. , 2005, Biomaterials.

[8]  Matt Brown PDT: light at the end of the tunnel? , 2003, Drug Discovery Today.

[9]  R. Iler The Chemistry of Silica: Solubility, Polymerization, Colloid and Surface Properties and Biochemistry of Silica , 1979 .

[10]  R. Pugh,et al.  Industrial manufactured silica nanoparticle sols. 2 : Surface tension, particle concentration, foam generation and stability , 2009 .

[11]  R. Tan,et al.  Novel Formulation of Large Hollow Nanoparticles Aggregates as Potential Carriers in Inhaled Delivery of Nanoparticulate Drugs , 2006 .

[12]  Keith Masters,et al.  Spray drying handbook , 1979 .

[13]  F. Iskandar,et al.  In Situ Production of Spherical Silica Particles Containing Self-Organized Mesopores , 2001 .

[14]  S. Eksborg,et al.  Stability of 5-aminolevulinic acid in aqueous solution. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Reinhard Vehring,et al.  Pharmaceutical Particle Engineering via Spray Drying , 2007, Pharmaceutical Research.

[16]  Yu Zhang,et al.  Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. , 2004, International journal of pharmaceutics.

[17]  Indrajit Roy,et al.  Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.

[18]  C. Remuñán-López,et al.  Microencapsulated chitosan nanoparticles for lung protein delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  Kikuo Okuyama,et al.  Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. , 2003, Journal of colloid and interface science.

[20]  C. Brambilla,et al.  Photodynamic therapy: where do we go from here? , 2003, European Respiratory Journal.

[21]  P. Choyke,et al.  Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica , 2008, Nanotechnology.

[22]  Jiju Antony,et al.  Design of experiments for engineers and scientists , 2003 .

[23]  K. Rollins,et al.  Full-Scale Field Testing of Colloidal Silica Grouting for Mitigation of Liquefaction Risk , 2007 .

[24]  D A Weitz,et al.  Onset of buckling in drying droplets of colloidal suspensions. , 2005, Physical review letters.

[25]  B. Bataille,et al.  Development of spray-dried acetaminophen microparticles using experimental designs. , 2000, International journal of pharmaceutics.

[26]  Invagination during the collapse of an inhomogeneous spheroidal shell , 2004 .

[27]  Yasusi Tanasawa,et al.  An Experiment on the Atomization of Liquid by Means of an Air Stream (the 2nd Report). , 1937 .

[28]  J. Heyder,et al.  Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .

[29]  Lichun Dong,et al.  The Study of the Surface Tension of Charge‐Stabilized Colloidal Dispersions , 2005 .

[30]  Jagdeep Shur,et al.  The Spray Drying of Unfractionated Heparin: Optimization of the Operating Parameters , 2008 .

[31]  François Guillemin,et al.  Nanoparticles as vehicles for delivery of photodynamic therapy agents. , 2008, Trends in biotechnology.

[32]  F. Galindo-Rosales,et al.  Intrinsic viscosity of SiO2, Al2O3 and TiO2 aqueous suspensions. , 2006, Journal of colloid and interface science.

[33]  R. Langer,et al.  Formulation and Physical Characterization of Large Porous Particles for Inhalation , 1999, Pharmaceutical Research.

[34]  K. Moghissi,et al.  Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? , 2003, European Respiratory Journal.

[35]  H Stepp,et al.  Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[36]  J. Kennedy,et al.  IN VITRO AND IN VIVO PROTECTION AGAINST PHOTOTOXIC SIDE EFFECTS OF PHOTODYNAMIC THERAPY BY RADIOPROTECTIVE AGENTSWR–2721 ANDWR–77913 , 1988 .

[37]  F. Iskandar,et al.  Self‐organization kinetics of mesoporous nanostructured particles , 2004 .

[38]  Mehrdji Hemati,et al.  Fluidized bed coating and granulation: influence of process-related variables and physicochemical properties on the growth kinetics , 2003 .

[39]  Jian Liang,et al.  Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior , 2007 .

[40]  A. Healy,et al.  Excipient-free nanoporous microparticles of budesonide for pulmonary delivery. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  T. Okubo Surface Tension of Structured Colloidal Suspensions of Polystyrene and Silica Spheres at the Air-Water Interface , 1995 .